However, tumour tissues from Taxol or PTX/PEG2k-Fmoc-NLG(L) groups had lower percentages of T cells including Treg, CD4+ and CD8+ T cells, but higher percentage of MDSC than the group treated with PEG2k-Fmoc-NLG(L) alone. This evidence concerns the gene CD8A and neoplasm.